Last reviewed · How we verify

NCT07100756: vertAIdo

Effectiveness of Implementation of Opportunistic AI-screening for Vertebral Fractures in Clinical Practice

Active, enrolled Last updated 3 August 2025
What this trial tests

trial testing AI vertebral fracture diagnostics (Flamingo) in Vertebral Fracture in 10,500 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
20 October 2023
Primary endpoint
19 May 2025
19 February 2026

Quick facts

Lead sponsorUniversity Hospital, Linkoeping
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment10,500
Start date20 October 2023
Primary completion19 May 2025
Estimated completion19 February 2026
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Linkoeping

Who can join

50 and older, any sex, with Vertebral Fracture or Osteoporosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate clinical effectiveness and cost-effectiveness after implementing a medically approved and commercially available AI support system for opportunistic vertebral fracture screening in CT examinations within an adapted fracture care pathway (integrated care process) in clinical routine. Data will be compared to historical data (same period the previous year). The main question it aims to answer is: Does opportunistic AI-supported vertebral fracture screening in CT examinations integrated to a fracture care pathway increase the numbers of diagnosed vertebral fractures compared to usual care? CT scans in the clinical routine care will be opportunistically screened for vertebral fractures by the AI for 4 months. All positive findings will be confirmed by a radiologist and triaged by the FLS (Fracture Liaison Service).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Clinical implementation of AI for vertebral fracture detection in CT aligned with fracture liaison services: high prevalence of undiagnosed vertebral fractures.
    Woisetschläger M, Baldimtsi E, Lindblom M, Davidson T, et al · · 2026 · PMID 41805842 · DOI 10.1007/s00198-026-07907-9

Verify or expand the search:

Other recruiting trials for Vertebral Fracture

Currently open trials in the same condition.

Other University Hospital, Linkoeping trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07100756.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing